Learn more about a new study claiming that GLP-1s could be used to treat cognitive conditions like dementia, but may pose a ...

The study also suggested that Ozempic and similar drugs can lead to an increase in the risk of nausea and vomiting, as well as arthritis and low blood pressure that can lead to fainting. In the study, ...

A study by the Department of Veterans Affairs says that drugs like Ozempic can do plenty more than just help with weight loss ...

When children with obesity undergo weight-loss treatment, the effects have repercussions later in life and the risk of serious health problems and premature death is lower as they reach young ...

A new study found that GLP-1 medications like Ozempic can lower your risk for 42 conditions, including dementia. Here's what ...

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

A gut microbe could naturally regulate sugar cravings and blood sugar levels, offering a promising alternative to drugs like ...

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

Just before leaving office, the Biden administration has announced costly GLP-1 drugs often used for weight loss are among the 15 medications listed in the next round of Medicare price negotiations.

A new study from the Department of Veteran Affairs, published in Nature Medicine, found that GLP-1 weight loss drugs including Mounjaro, Ozempic, Wegovy and Zepbound, may offer benefits beyond weight ...